Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Report links antibiotic use and resistance
Overall, the report says the use of antibiotics is higher in food-producing animals than humans, but this varies depending on the country and type of antibiotic.
EU agencies explore AMR in farm animals and humans 

A new European report confirms the link between antibiotic consumption and antibiotic resistance in both humans and animals. It also shows the UK use of antibiotics in farm animals is low compared to many other European countries.

The report is the second of its kind and has been published by the European Centre for Disease Control, the European Food Safety Authority and the European Medicines Agency.

Overall, it says the use of antibiotics is higher in food-producing animals than humans, but this varies depending on the country and type of antibiotic.

Polymyxins, a class of antibiotics that includes colistin, are used widely in the veterinary sector and is being used increasingly in hospitals to treat multi-drug-resistant infections, the report says.

However, third and fourth generation cephalosporins and quinolones - which are considered critically important for human health - are used more often in humans than animals.

Resistance to quinolones (which are used to treat salmonellosis and campylobacteriosis in humans) is associated with the use of antibiotics in animals, according to the report. The use of third and fourth generation cephalosporins for infections caused by E. coli and other bacteria in humans is associated with resistance to these antibiotics in E. coli found in humans.

The secretary-general of RUMA, John Fitzgerald, welcomed the report but said the situation is likely to change rapidly as awareness increases.

“The UK’s most recent Veterinary Antimicrobials Resistance and Sales Surveillance (VARSS) report on 2015 sales data saw a 10% drop in antibiotics sales into food-producing animals compared with the previous year,” he said.

“This, alongside significant reported reductions in usage in the poultry and pig sectors – released via the recent British Poultry Council Stewardship Report and AHDB’s e-Medicine Book data – will have changed the picture again.”

Mr Fitzgerald said each local situation in each country needs its own multifaceted approach to dealing with antibiotic resistance.

“There has been a tendency for critics to promote alternative farming systems or demand blanket implementation of rules in other countries, when what we actually need is to reduce use in a sustainable way that safeguards animal welfare,” he added.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.